Evaluating the Impact of the Intervention of a Pharmacist in the Operating Room on the Appropriate Use of Sterile Medical deviceS

Surgery Clinical Trial

— OPTIBLOC  

Official title:

Pilot Study Evaluating the Impact of the Intervention of a Pharmacist in the Operating Room on the Appropriate Use of Sterile Medical Devices and the Economic Repercussions

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04423250
• Other study ID #: NIMAO/2016/JMK-01
• Status: Completed
• Start date: March 23, 2018
• Est. completion date: October 31, 2018

Study information

• Verified date: June 2020
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

assess the impact of the intervention of a clinical pharmacist expert in sterile medical devices

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: October 31, 2018
• Est. primary completion date: October 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• - The patient must be a member or beneficiary of a health insurance plan.

• The patient is managed for scheduled surgery (full hospitalization or outpatient) in the UDG (Urology Digestive Gynecology) operating room.

Exclusion Criteria:

• - The subject is in a period of exclusion determined by a previous study.

• The subject is under judicial protection.

• The subject (or his/her legal representative) has expressed his/her opposition to participate in the study.

• The patient is undergoing emergency surgery in the UDG (Urology Digestive Gynecology) operating room.

• It is not possible to give informed information about the subject.

Translated with www.DeepL.com/Translator (free version)

Related Conditions & MeSH terms

• Infertility
• Surgery

Intervention

Other:
• impact of the intervention of a clinical pharmacist with expertise in sterile medical devices on non-compliances related to the use of sterile medical devices
- Failure to trace, Lack of product information, absence of product in the operating room

Locations

Country	Name	City	State
France	CHU de NIMES	Nîmes

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	identify compliance with the appropriate use of sterile medical devices		1 day